InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-10 · accession 0001127602-25-017337 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-11 2025-06-10 GILD Telman Deborah H EVP, GC, Corp. Affairs F - Tax $110.09 -430 37.8K -1% -$47.3K
D 2025-06-11 2025-06-10 GILD Telman Deborah H EVP, GC, Corp. Affairs M - OptEx — +1,313 38.2K +4% —
D 2025-06-11 2025-06-10 GILD Telman Deborah H EVP, GC, Corp. Affairs M - OptEx — -1,313 30.4K -4% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-10 F D 430 $110.09 37,801 D — —
2 Common Common Stock 2025-06-10 M A 1,313 — 38,231 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Derivative Restricted Stock Unit 2025-06-10 M D 1,313 — 30,389 D — · — to — 1,313 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.